A new drug developed by Australian researchers has shown promising results in reducing sepsis in a Phase II clinical trial involving 180 patients. The carbohydrate-based treatment works by calming a ...
For decades, Africa's role in HIV research was framed as that of a peripheral "host, not driver". The just-concluded 2025 International Aids Society (IAS) conference in Kigali made it unmistakably ...